+ read bio

At Good Growth, Maureen does most sourcing for the startups coming out of MIT and the wider Boston and New England community. She is an active member of MIT's Angel community, sourcing deals from the groups in Boston, New York, and California. Maureen leads GGC's due diligence for GreenTech startups and assists Amy with due diligence on HealthTech deals. She also serves on the Board for GGC portfolio company Aralez Bio, Blue Ocean Gear, Eden GeoTech and Radical Plastics, and she is an observer on GGC portfolio companies Liminal, Leuko and Encora Therapeutics.

Maureen has 25+ years of strategy and operations experience with tech startups and worldwide tech strategy practices. Before GGC, Maureen was the co-founder & COO of Ignition Ventures, which co-founded and invested in multiple tech startups. At Ignition, the team would find transformative technologies, work with the CTO and team to build the strategy, find critical customer targets, raise money and / or find an acquisition target. Maureen started her career in strategy consulting at Bain & Company, where she was a consultant and team leader in both the Boston and Sydney, Australia offices. She then became an Associate Partner at IBM's Strategy practice. She served as IBM Head of Global Strategy Thought Leadership for four industries. She has more than seven years of international work experience in Asia, including Hong Kong and Australia.

Maureen has been a Lecturer at MIT, leading numerous classes in Engineering and Management, and has been a Mentor for MIT’s Sandbox Innovation accelerator since launching in January 2016. She has also been a part-time Consultant to Sandbox to help with its growth strategy, as it grew from 40 startups a year to 400+ startups each semester. Before her graduate degree, Maureen worked as a Civil Engineer for the US Peace Corps in Fiji, designing and helping to build small water systems.

+ read bio

Amy Salzhauer is a Founder and Managing Partner at Good Growth Capital, a majority women-owned venture capital fund that is known for its world-leading expertise in technology commercialization, and for finding, funding and growing superior, defensible technology companies that fill pressing societal needs. She was previously the CEO of Ignition Ventures, where she helped start companies worth over US $1 billion out of science labs in areas such as chip-based fuel cells, self-organizing networks, selective brain cooling, and advanced materials.

Amy is an inventor who holds several patents, speaks internationally about entrepreneurship and leadership, and serves on multiple for-profit and non-profit boards, including GGC portfolio companies Leuko, Obsidio, and Coagulo and as Treasurer of the Roper St Francis Hospital Foundation Board and the Advisory Board of the Arizona State University Interplanetary Initiative. Her prior experience also includes writing for magazines like Newsweek, Science, Technology Review, and Harvard Business Review and serving as the Assistant Director of a non-profit environmental organization in Washington D.C. Her many recognitions include being selected by the World Economic Forum as one of its one hundred top “Global Leaders for Tomorrow," and being chosen multiple times as a top “40 Under 40” business leader. Amy holds an MBA from MIT; an M.Phil in Plant Sciences from Cambridge University where she was a Herschel Smith Harvard Scholar; and an A.B. magna cum laude from Harvard University.

+ read bio

At Good Growth, Carolyne is the head of the Data Sciences team, leading due diligence for startups with software, AI, analytics, or business intelligence components. Carolyne also assists in due diligence for HealthTech companies that have a data sciences component. Working with founders, Carolyne helps bring their visions to life, so others can understand how emerging technologies can positively impact and create a more sustainable future. She is on the board of Good Growth portfolio company Unison, new open-source software that will make cloud computing simple and accessible.

Carolyne has over 20 years of experience bringing products to market from ideation to launch. Before GGC, Carolyne worked at Apple for 10+ years, having established and led Apple products that now account for over half a Trillion dollars in Apple’s revenue. Carolyne started her Apple career as the lead producer for the iTunes Music Store US, establishing and leading the store teams and developing the content management system. She has negotiated deals with content providers across Europe and successfully launched and led iTunes Europe. Carolyne returned to Cupertino to lead several stealth projects within Apple and with Apple’s top leadership team, including launching and leading the App Store into 62 countries simultaneously; this was unprecedented in the tech industry at that time.

Carolyne has advised Fortune 100s and multiple startups, creating two startups, one of which is still an ongoing concern. She has worked in the music industry, with global talents helping bring their music to the world.

+ read bio

At Good Growth Capital, David focuses on GGC’s due diligence in both HealthTech and GreenTech for those companies that have developed and use new materials and assess some of the Hard Sciences deals that have complex supply chains. As an experienced Venture Capitalist, David is critical in the formation and fund administration of Good Growth Capital. He serves on the Board for GGC portfolio companies Ateios and NALA systems.

David has 20+ years of experience investing in startups globally. Before GGC, David was the Managing Director for Techstars/Arcadis City of 2030 Accelerator (SmartCity focused) in Amsterdam, Netherlands where he led the mentoring, development and launch of 20 portfolio companies. He was also the Co-Founder and Managing Partner of Capital A Partners "CapA", which realized 54%+ IRR or 8x+ multiple on Invested Capital. David also was the Managing Director at Katalyst Venture Partners in NYC, which was a MediaTech-focused fund.

David has co-founded and successfully exited from Supplybase.inc in 2000, Supplybase was a B2B supply chain software company and was successfully acquired by I2 Technologies, which was subsequently obtained by JDA Software. He also has previous experience in several operational roles in engineering, business development, and sales with GE, DuPont and Conoco, in the U.S. and U.K.

+ read bio

At Good Growth, John leads the Fintech investments and leads sourcing in the US Southeast, predominantly in South Carolina and North Carolina’s Research Triangle. John is critical in assessing deal terms across all Good Growth’s investments as well as helping startups determine the right financial strategy. He is a Board member on GGC’s portfolio companies Bone Health and a Board Observer on portfolio company Lindy BioSciences.

John has 15+ years’ experience in helping startups and independently owned businesses. Before GGC, John was the Executive Administrator of Charleston Angel Partners in 2016 where he sourced and facilitated the cumulative investments of over $10M in early-stage companies by accredited investors. He has also co-founded The Harbor Entrepreneur Center, a non-profit initiative dedicated to creating collision among entrepreneurs in the region. John served as its first executive director for 5 years, during which, he mentored 80 startup companies participating in the Harbor Accelerator program. John was also founder & CEO of Fundingcharleston.com.

John has also served as the Chairman of the Charleston Young Professionals group and board member of the Charleston Metro Chamber of Commerce. He was selected in the 2013 class of the CRBJ’s 40 under 40 award, 2014 50 Most Progressive by CHARLIE magazine, and was honored with the 2013 visionary of the year award by Azalea Magazine for launching fundingcharleston.com and The Harbor Entrepreneur Center. He also has previous experience in various roles in the financial services industry, including commercial banking, private banking, and wealth management for Regions Bank and Bank of America.

+ read bio

At Good Growth, Sophie is responsible for managing the inbound deal flow process, performing diligence on prospective investments and assisting with fund administration, including tracking key metrics, preparing fund raising documents and marketing

Experience in public affairs, market research, and business development

BA Government, Harvard University

+ read bio

Jennifer is responsible for leading fundraising and investor relations efforts at Good Growth Capital. She focuses on building and enhancing relationships with new and existing investors and consultants.

Jennifer joined the Firm from HarbourVest Partners, most recently on the ESG team where she focused on working with clients to understand and help achieve their ESG objectives. Additionally, she worked with internal stakeholders to implement and monitor ESG standards and practices across the portfolio to advance the principles of sustainable investing. Prior to joining the ESG team, Jennifer was part of the institutional investor relations team at HarbourVest, where she supported the development of relationships with existing and prospective investors and assisted with the Firm’s fundraising efforts. Jennifer previously worked in Institutional Equity Research Sales at Wells Fargo Securities. Prior to that, she worked at Wellington Management Company.

Jennifer received a BS in Business Administration in Finance and International Business from the University of Tennessee, and an MBA from Yale School of Management.

+ read bio

At Good Growth Capital, Aditi focuses her time on exploring the opportunities and cutting edge of data science.

Prior to GGC, Aditi was the senior associate at Invest Detroit Ventures, the most active early stage investor in Michigan. At IDV, Aditi was focused on new deal and KPI development, and cultivating relationships with entrepreneurs and ecosystem partners across the Great Lakes region. Aditi started her career at IBM where she worked on proprietary and open source cloud infrastructure products including IBM Cloud, Kubernetes, OpenStack and Docker. During her time in graduate school she interned at various venture funds and at CoderPad where she worked in product and data operations.

Aditi received a BSE in Computer Engineering from University of Michigan, and a dual degree MBA/MS Data Science from University of Virginia’s Darden School of Business.

+ read bio

Sam is an Associate at Good Growth Capital, and he spends his time focused on identifying and evaluating transformative life sciences companies that aim to address areas of unmet patient need.

Before joining GGC, Sam worked as a life science consultant where he provided strategic insights to biotech and pharmaceutical clients, specializing in commercial due diligence, indication expansions, market access, medical affairs, and go-to-market strategies.

Sam graduated from Colby College in Waterville, ME, with a Bachelor's degree in Biology. While at Colby, he worked as a research assistant in Professor Ron Peck's microbiology lab.

+ read bio

Mary-Kate is the Operations Manager at Good Growth Capital, where she is responsible for structuring and strengthening the Firm’s internal processes, policies, information design, security, and workflows. Prior to joining the Good Growth team, Mary-Kate worked as an independent consultant advising clients in design and marketing strategy, web development, and fundraising across a range of industries. She also worked as Director of Operations at Ignite Glass Studios in Chicago. Mary-Kate holds her BA in Linguistics from the University of Oregon, and MA in Design and Management from Ming Chi University of Technology.

+ read bio

Executive Director, Association of Marshall Scholars

Former Director of Programming and Education, Edward M. Kennedy Institute for US Senate

Former Faculty RISD Digital+Media Dept. and Mass College of Art & Design

Harvard PhD; MIT Media Lab MS; Oxford MS; Yale BA

+ read bio

Bob is a senior executive with over 30 years of leadership experience in healthcare services, healthcare IT, and surgical devices with major international companies, as well as entrepreneurial startups and venture capital. He is well recognized for creating value, with experience in mergers and acquisitions, public corporations, venture capital firms, and startups. Today, Bob is leveraging his healthcare industry and venture capital experience as the Managing Director of Hotspot Ventures, LLC. Hotspot Ventures only works with private capital backed healthcare companies as a strategic advisor, independent board member or executive chairman.

Bob is a venture partner with Good Growth Capital, a venture capital firm in Charleston, SC, the executive chairman of the board for OrbitalRx, a pharmacy shortage supply chain software company in Winston Salem, NC, a strategic advisor and operating partner for Bronze Valley, a CDFI focused on investing in companies founded and/or led by diverse entrepreneurs in Birmingham, AL, is a member of the board of directors for AllerVie, an asthma and allergy practice rollup company in Dallas, TX, is an executive in residence for HealPros, a HEDIS Stars gap closure company in Atlanta, GA, is the executive chairman for Pictor Labs, a digital pathology staining company in Los Angeles, CA, and a strategic advisor for Avanos, a publicly traded medical device company in Atlanta, GA.

Prior to this work, he served as the founding managing director for the American Cancer Society’s BrightEdge Fund, where he built the back office, hired the initial team, led the first five investments, and realized an early exit in Castle Biosciences. Before BrightEdge, he was a partner at Harbert Growth Partners in Birmingham, AL. He led investments in WellCentive, IngagePatient, Caresync and Shipt. He also served as the board observer for nContact, MaxCyte, OpenQ and WiserTogether. Bob also served as the senior vice president/ general manager of the Pharmaceutical Services Division at US Oncology, a privately held, vertically integrated cancer care provider network with cancer clinics in more than 440 sites of service and a physician network consisting of over 1200 medical oncologists and radiation oncologists that was acquired by McKesson.

Prior to US Oncology,he was a senior executive at CardinalHealth where he served as vice president/ general manager of New Ventures. Prior to Cardinal he was the founder and CEO of Surgical Innovations & Services, Inc.(SIS). Under his leadership, SIS became a leader in the emerging outsource management sector, with over 300 hospitals and surgery centers under contract before being acquired by PhotoMedex.

Bob is a graduate of the University of Georgia and holds Bachelor of Scien ce degrees in Political Science and Chemistry and resides in Charleston, SC.

+ read bio

Professor Elkins- Tanton is the Foundation and Regents Professor, School Of Earth and Space Exploration at Arizona State University. She is a Vice President and Regents Professor of the Interplanetary Initiative at ASU and Principal Investigator at the NASA Psyche mission. She was on the Faculty of MIT for four years, teaching undergraduate and graduate courses in planetary geology and spent five years as a researcher at Brown University. Before that, Lindy spent eight years working in business, with five years spent writing business plans for young high-tech ventures.

Professor Elkins-Tanton received her bachelor's and master's degrees from MIT. After woking in business, she returned to MIT for her PhD.

+ read bio

Founding Exec Director, Deshpande Center at MIT and Stevens Center at USC

Vice Provost for Innovation at USC

Founder of MAKE IT IN LA, an initiative by LA’s mayor

Former Advisor / Council Chair / Steering Committee: World Economic Forum, US National Advisory Council for Innovation and Entrepreneurship, National Academy of Engineering

TEDx – Creator, Curator & Host for first ever TEDx

Co-founder Stylus Innovation Inc. (acq by Artisoft)

MS & BS, Mechanical Engineering, MIT

+ read bio

Founder and Managing Partner of the Katama Group, consulting for international strategy

Leader in VCs and startups for many years, including positions such as Global Managing Director of SOSV Accelerator and SVP of Techstars

Former Director of Emerging Business, Facebook

Served in multiple firms in International Business Development, and notably served in the US Department of Commerce as Senior Director, Export Promotion and Trade Policy, for the International Trade Administration

JD from Harvard Law, a MIA of International Affairs from Columbia University and his AB from Harvard College

+ read bio

Executive Director, MIT Center for Collective Intelligence and Senior Director, MIT Horizon

Lead organizer of The Engine, a new MIT initiative created to advance innovation

Former President, MIT Technology Review, and President, MIT Enterprise Forum

+ read bio

Konduros, a licensed attorney since 1990, founded SK Strategies in 2004 – a SC-based consulting firm that specializes in economic development, strategic planning, championing major corporate initiatives, public-private partnerships, integrated marketing & business development strategies, innovation, and vision-mission-brand development – and has guided and supported major institutional and private sector clients over the past two decades ranging from Clemson University to Greenville Health System. He has a demonstrated track record and specialization in industries ranging from advanced manufacturing to healthcare and life sciences. He has also spearheaded major economic development initiatives in multiple corporate roles since 1989, when he joined the SC Department of Commerce after graduating from law school. He is a graduate of Clemson University (1985 magna cum laude, Rhodes Scholar finalist), the University of South Carolina School of Law (1989), and the University of Oklahoma Economic Development Institute (1993). Additionally, Konduros obtained his real estate license in 2012.

Highlighted defining career leadership positions include Konduros being tapped at age 30 to lead North American operations for Germany-based automotive supplier Alfmeier Corporation (1990-1994) while also serving as Co-Chair of the BMW Supplier Council, founding President/CEO of Upstate SC Alliance (regional economic development organization 2000-2004), Clemson ICAR’s Economic Development & Marketing Consultant/Senior Development Counsel and ITOR’s Business Development Director (Institute for Translational Oncology Research) as President of SK Strategies (2005-2014 time frame). During that same period of his career, Konduros also served in voluntary leadership roles as Board Chairman for the Greenville Chamber of Commerce (2011), the Greenville Chamber Foundation (2012), and the Cancer Society of Greenville (2013) along with being a director on multiple boards and councils.

Following an 11-year affiliation with Greenville Health System (now Prisma Health), most recently as Executive Director of the Greenville Health Research Development Corporation which championed innovation and industry partnership strategies for one of the largest healthcare providers in the Southeast US, Konduros served as President/CEO of SCBIO (South Carolina Biotechnology Industry Organization) from 2017 to 2021. In that transformational leadership role he focused on scaling-up and leading the innovative statewide economic development and trade organization to its next level of development – fueled by its mission to build, advance, innovate, and grow the life sciences industry and ecosystem in South Carolina and the Southeast US Region, working closely with strategic partners from industry, academia, and the public/private sector - including complementary local, regional, state, and national economic development agencies and industry/trade associations such as the SC Department of Commerce, SC Chamber of Commerce, BIO, PhRMA, AdvaMed, SEMDA and SEBIO among others.

Under Konduros’ leadership, SCBIO more than tripled revenue within 3 years and became a formally recognized economic development force in South Carolina and beyond, culminating with the Governor formally proclaiming SCBIO Life Sciences Week during Konduros’ final month in his CEO role (which was quickly followed by organizational achievement of unprecedented legislative funding). SCBIO’s core mission areas included spearheading high-impact initiatives in economic development, advocacy, integrated marketing, innovation/R&D, convening stakeholders (including hosting the state’s largest life sciences conference annually with record breaking attendance for consecutive years), capital attraction and ultimately helping to improve the delivery of healthcare. Konduros was also recruited to serve as President/CEO of KOR Medical in 2021 and on the Vikor Scientific Board of Directors. As CEO, he led efforts to rapidly and strategically build and develop the innovative personalized medicine-focused clinical cannabis life sciences company, and ensure a successful launch of its initial national product portfolio within 7 months, as the newest division of Vikor.

Konduros currently serves on the South Carolina Chamber of Commerce Board & Executive Committee as well as South State Bank’s Greenville Advisory Board and the Palmetto Conservation Foundation Board. He has recently served on the Southeast US Life Sciences Association Board, the Carolinas Healthcare Innovation & Technology Association Advisory Council, SC Research Authority Biotech Innovation Advisory Council.

Konduros received the Order of the Palmetto from SC Governor Henry McMaster in 2017 (SC’s highest civilian honor), was named to Greenville’s 50 Most Influential People Hall of Fame in 2019, the Chairman’s Award for the Greater Greenville Chamber of Commerce (2008 & 2010), was formally designated as a Knowledge Economist by the South Carolina Research Authority (2007), and was named a South Carolina Ambassador for Economic Development by Governor Jim Hodges (2001). In addition to his current leadership roles, Konduros has also served on the South Carolina Independent Colleges & Universities Board of Directors, Clemson University’s College of Business & Behavioral Science Advisory Board, as Vice Chair for the Board of the American Red Cross Upstate SC Chapter, and as Chair of the Upstate SC Air Service Partnership Committee on behalf of GSP International Airport – charged with helping to successfully recruit Southwest Airlines to Greenville-Spartanburg which propelled unprecedented growth of that world-class facility.

+ read bio

Physician for Sports Medicine and Concussions

Team Physician for multiple US National Teams and Pro Sports Teams (Washington Nationals, MLB; DC United, MLS, US Canoe/ Kayak, US DragonBoat, Special Olympics)

Researcher at NIH/NCI

10-time World champion paddler; US Olympic Rowing team double scull, 1996

+ read bio

Special Advisor to the President for Corporate Relations at the Medical University of South Carolina (MUSC)

Former Board member, COO, President and Head of R&D, Forest Laboratories

Former President and CEO of Celsion Corporation

Co-founder of the Technology Accelerator Company; TAC Development LLC Advisor

Former Sr VP Clinical Research and Development at Sandoz Pharmaceutical Corporation.

Former Corporate VP-Clinical Development and Medical Affairs at The Upjohn Company

BSChE, Tufts; MS, Rutgers, PhD Biomedical Engineering and MD, Case Western Reserve

+ read bio

Serial Entrepreneur

Director of Product at Tempus, Precision Medicine via AI
VP of Product at Zest Health

Northwestern U, MS Comp & Info Systems U of Michigan, BA

+ read bio

CTO & Founder Ember
CEO & Founder BlueDot /weMonitor

Founder of Wireless Industrial Network Alliance & Cool Energy World
IoT Consultant
Board Member ViE Tech

MIT PhD Media Lab

+ read bio

Founder and Director MIT Alumni Angels (Boston Healthcare & West Coast )

President & CEO, Savran Technologies

Serial Entrepreneur: President and CEO of: Cerno Fluidics, Sonogenix, Bioabsorbable Therapeutics (acq by Multi- Cell Corporation), SMART Therapeutics (acq by Boston Scientific); VP of Target Therapeutics (acq by Boston Scientific)

MBA, MIT; BA Harvard

+ read bio

Dave has more than 30 years of experience leading technology change at large, multinational companies including AstraZeneca, GE, Honeywell and Flextronics. Most recently, Dave was VP of Software Engineering at Apple Computer where his team was responsible for building, deploying, and running digital solutions across the $365B revenue company. Dave has a degree in Computer Science from Cle mson and an MBA from the University of Virginia Darden School of Business.

+ read bio

Over 30 years building companies and high performance teams

Principal – Momenta Consulting

CEO, Intac International. Private equity-backed, sold in 2017

CEO and co-founder of PlumRiver Technology (now PlumRiver software)

Principal, Bell Tower Partners

+ read bio

Prof of Medicine & Oncology; Johns Hopkins University School of Medicine:

Clinical Chief, Division of Pulmonary and Critical Care; Director, Interventional Pulmonology; Director, Interventional Pulmonary Outcomes Group

Johns Hopkins, MBA; Harvard, PB; Emory, DO, UNE, BA